Dalibor Novotný

Evaluation of Total Adiponectin, Adipocyte Fatty Acid Binding Protein and Fibroblast Growth Factor 21 Levels in Individuals With Metabolic Syndrome

Dalibor Novotný, H Vaverková, David Karásek et al. · Physiological Research · 2014 · 37 citations · Full text

Metabolic Disorder, Pathology, Mets+ Patients +16

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients

Dagmar Horáková, Kateřina Azeem, Radka Benešová et al. · International Journal of Endocrinology · 2015 · 33 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +15

Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia

H Vaverková, David Karásek, Dalibor Novotný et al. · Atherosclerosis · 2007 · 27 citations

Inflammation, Metabolic Syndrome, Vascular Disease +13

BENEFITS OF THREE-MONTH CONTINUOUS GLUCOSE MONITORING FOR PERSONS WITH DIABETES USING INSULIN PUMPS AND SENSORS

Karolina Peterson, Jana Zapletalová, Pavla Kudlová et al. · Biomedical Papers · 2009 · 26 citations · Full text

Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis

H Vaverková, David Karásek, Dalibor Novotný et al. · Clinical Biochemistry · 2009 · 25 citations

Metabolic Syndrome, Cardiovascular Epidemiology, Cardiovascular Disease +12